Stockreport

Why The Narrative Around Sangamo Therapeutics Is Shifting After Recent Analyst and FDA Updates [Yahoo! Finance]

Sangamo Therapeutics, Inc.  (SGMO) 
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sangamo.com
PDF The fair value estimate has dipped from $4.10 to $3.25, with analysts adjusting assumptions based on both encouraging milestones and persistent headwinds. These include [Read more]